INNOVATION AND CONTRACT RESEARCH ORGANIZATION
WASSC TECH is a biopharmaceutic research company focused on the development of antibody drug conjugate (ADC) against cancer and vaccine that’s offering its expertise and equipment as a contract research organization to help companies with their challenges. A multidisciplinary team composed of chemist, bio-chemist and biologist that takes different angles to tackle their obstacles and find solutions!
#why-wassc? ADC'S LATEST TECHNOLOGY !
WASSC Tech is a company dedicated to the advancement of antibody and ADC development and vaccine creation, specializing on site-specific bioconjugation, drug design, and related fields. One of our main objectives is to establish a novel category of ADCs, overseeing every stage from development to manufacturing. Moreover, WASSC’s overarching mission involves the creation of technologies for precise site-specific conjugation, no matter the biomolecule involved.
“OUR EXPERTISE AT YOUR SERVICE
All the tools that we have developed internally are now available for your company. Ask us a quote !
See below all the services we offer.
✔️ADC DESIGN AND OPTIMIZATION SERVICES ✔️BIOCONJUGATION SERVICES
✔️PEPTIDES SERVICES ✔️DRUG DESIGN SERVICES
✔️BIOANALYSIS AND CHEMICAL SERVICES ✔️FORMULATION SERVICES
✔️BIOLOGY : PROTEIN AND MOLECULAR SERVICES ✔️FORMULATION SERVICES
✔️CONSULTATION SERVICES
Dr. Simon Beaudoin PhD, Biochemist
– our ceo and founder
My passion for science is what makes WASSC’s innovative!
Dr. Simon Beaudoin, CEO of WASSC Technologies, CTSO of Defense Therapeutics and Co-Founder of Defence Therapeutics.
Simon has received a PhD in biochemistry at Sherbrooke’s University in 2013. His expertise in biochemistry, molecular and cellular biology greatly contributed to the conceptualization, realization and valorization of the Accum™ technology. A platform publicly traded on TSX (Defence Therapeutics).
With a strong expertise in the area of bio-conjugation and particularly, in the development and optimization of ADC, vaccines and radio-immuno-conjugates for diagnostic applications. His impressive work has been covered in many highly respected scientific journals. Simon is also the recipient of 15 peer-reviewed awards and scholarships.
Inventor of several patent-pending technologies (8) related to vaccines, ADC and drug delivery systems. Illustrating the impact of his work on the scientific community. Simon is also the recipient of life science entrepreneurship grants and certifications. The reach of his projects allowed for multiple collaborations with internationally renowned academic and industrial partners in the field of ADCs and vaccines as a Key Opinion Leader. »
– we can assist you
Accelerate, Develop, Create !
– Our multidisciplinary team